2m 2m 2m 2m 2m 2m 2m
Xenon Pharma (XENE)
NASDAQ
$54.60-$0.20 (-0.36%)
Price as of Jun 23, 2026 4:10 PM EDT- $5.3BMarket Cap
- 73.99%1-Year Change
- BiotechnologyIndustry
Xenon Pharma (XENE)
$54.60-$0.20 (-0.36%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 7.5M -20.50% | 9.4M 0.00% | 9.4M 0.00% | 9.4M -48.83% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 7.5M -20.50% | 9.4M 0.00% | 9.4M 0.00% | 9.4M -48.83% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -300.9M +43.04% | -210.4M +25.60% | -167.5M +58.38% | -105.8M +40.16% | |
Depreciation and Amortization Expense | 2.5M -0.66% | 2.6M -27.70% | 3.5M +118.04% | 1.6M +79.25% | |
Total Operating Expenses | 380.6M +36.26% | 279.3M +30.48% | 214.1M +54.47% | 138.6M +42.23% | |
Operating Profit | -373.1M +33.57% | -279.3M +30.48% | -214.1M +65.75% | -129.1M +63.49% | |
Interest Income | 26.8M -36.04% | 41.9M +51.86% | 27.6M +217.00% | 8.7M +1,769.74% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | -484,000 0.00% | |
Interest Income and Expense and Net | 26.8M -36.04% | 41.9M +51.86% | 27.6M +235.64% | 8.2M +45,816.67% | |
Total Nonoperating Income and Expense | 28.2M -31.07% | 40.9M +30.32% | 31.4M +706.82% | 3.9M +703.31% | |
Income before Taxes | -344.9M +44.66% | -238.4M +30.51% | -182.7M +45.85% | -125.3M +58.78% | |
Income Taxes | 1.0M +124.85% | -4.1M +1,300.34% | -292,000 -347.46% | 118,000 +2,066.67% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -345.9M +47.62% | -234.3M +28.48% | -182.4M +45.48% | -125.4M +58.94% | |
Net Income from Continuing Operations Applicable to Common | -344.9M +47.18% | -234.3M +28.48% | -182.4M +45.99% | -124.9M +62.07% | |
Basic EPS and Net Income | -4.36 +44.85% | -3.01 +10.26% | -2.73 +32.52% | -2.06 +16.38% | |
Diluted EPS and Net Income | -4.36 +44.85% | -3.01 +10.26% | -2.73 +32.52% | -2.06 +16.38% | |
Basic Weighted Average Shares | 79.3M +1.74% | 77.9M +16.45% | 66.9M +10.48% | 60.5M +38.77% | |
Diluted Weighted Average Shares | 79.3M +1.74% | 77.9M +16.45% | 66.9M +10.48% | 60.5M +38.77% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 199.2M +39.56% | 142.7M -3.99% | 148.6M +159.67% | 57.2M -67.42% | |
Short-Term Investments | 349.7M -27.77% | 484.2M -1.07% | 489.4M -8.49% | 534.8M +42.21% | |
Cash and Cash Equivalents and Short-Term Investments | 548.9M -12.45% | 626.9M -1.75% | 638.1M +7.77% | 592.1M +7.31% | |
Total Current Assets | 560.6M -11.75% | 635.3M -1.50% | 645.0M +7.44% | 600.3M +7.38% | |
Accumulated Depreciation | 15.4M +14.74% | 13.5M +19.67% | 11.3M +29.25% | 8.7M -34.79% | |
Property and Plant and Equipment and Net | 8.7M -15.15% | 10.3M +6.47% | 9.7M +48.51% | 6.5M +45.54% | |
Total Long-Term Assets | 45.9M -66.70% | 137.8M -54.45% | 302.4M +123.73% | 135.2M +2,926.91% | |
Total Assets | 633.2M -20.67% | 798.1M -17.27% | 964.8M +27.93% | 754.1M +31.84% | |
Income Taxes Payable | 313,000 -94.50% | 5.7M N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 41.8M +17.43% | 35.6M +30.50% | 27.3M +20.13% | 22.7M +58.51% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 3.2M -58.16% | 7.6M -20.39% | 9.6M -3.45% | 9.9M +29.99% | |
Total Liabilities | 51.4M +18.89% | 43.2M +17.24% | 36.9M +12.95% | 32.6M +48.58% | |
Retained Earnings | -1.2B +38.46% | -899.5M +35.23% | -665.1M +37.78% | -482.7M +35.08% | |
Total Stockholders Equity | 581.8M -22.94% | 754.9M -18.65% | 927.9M +28.61% | 721.5M +31.17% | |
Total Shares Outstanding | 80.0M +4.70% | 76.4M +1.39% | 75.4M +20.42% | 62.6M +21.21% | |
Cash Flow | |||||
Cash from Operating Activities | -279.1M +53.88% | -181.4M +24.81% | -145.3M +47.65% | -98.4M +41.62% | |
Capital Expenditures | 799,000 -74.02% | 3.1M -45.26% | 5.6M +94.09% | 2.9M +41.17% | |
Cash from Investing Activities | 218.0M +32.12% | 165.0M +240.82% | -117.2M -60.42% | -296.0M +19.95% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 117.1M +865.48% | 12.1M -96.57% | 353.5M +26.95% | 278.5M -37.78% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -4,974.27% +68.02% | -2,960.55% +30.48% | -2,268.96% +65.75% | -1,368.91% +219.50% | |
Return on Assets | -48.33% +81.82% | -26.58% +25.27% | -21.22% +12.24% | -18.91% -8.77% | |
Return on Equity | -51.76% +85.85% | -27.85% +25.93% | -22.12% +12.15% | -19.72% -9.83% | |
Revenue Growth | -20.50% N/A | 0.00% N/A | 0.00% +100.00% | -48.83% +14.41% | |
Current Ratio | 13.42 -24.84% | 17.85 -24.52% | 23.65 -10.57% | 26.44 -32.25% | |
Cash Ratio | 4.77 +18.85% | 4.01 -26.43% | 5.45 +116.15% | 2.52 -79.44% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow